Germline DDX41 variants predispose to myeloid malignancies, most often MDS and AML and to a lesser extent chronic myelomonocytic leukemia (CMML) or myeloproliferative neoplasms (MPNs) (Figure 1B). Here, DDX41 is linked to chronic myelomonocytic leukemia.